{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:31:19Z","timestamp":1787902279222,"version":"build-2784847793"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.expneurol.2014.02.006","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T06:31:45Z","timestamp":1392359505000},"page":"8-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"special_numbering":"PA","title":["Molecular mechanisms linking neuroinflammation and neurodegeneration in MS"],"prefix":"10.1016","volume":"262","author":[{"given":"Erik","family":"Ellwardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Zipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2014.02.006_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.molmed.2010.11.006","article-title":"EAE: imperfect but useful models of multiple sclerosis","volume":"17","author":"'T Hart","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuron.2005.03.018","article-title":"Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL","volume":"46","author":"Aktas","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/brain\/awt324","article-title":"Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis","volume":"137","author":"Al-Izki","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0020","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/S1567-5769(01)00129-1","article-title":"Factors modifying the migration of lymphocytes across the blood\u2013brain barrier","volume":"1","author":"Alun Brown","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0025","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1073\/pnas.0502467102","article-title":"Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes","volume":"102","author":"Anikeeva","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF[alpha] promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.192.3.393","article-title":"Clonal expansions of Cd8+ T cells dominate the t cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction","volume":"192","author":"Babbe","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0040","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00415-006-0204-1","article-title":"Axonal protection achieved in a model of multiple sclerosis using lamotrigine","volume":"253","author":"Bechtold","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2010.07.007","article-title":"Involvement of IFN-\u03b3 and perforin, but not Fas\/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis","volume":"229","author":"Beeston","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0050","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s00330-009-1364-z","article-title":"MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study","volume":"19","author":"Bellmann-Strobl","year":"2009","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.20051060","article-title":"Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis","volume":"202","author":"Beyersdorf","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0060","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2R\u03b1-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"Binder","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0070","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/brain\/123.6.1174","article-title":"Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation","volume":"123","author":"Bitsch","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1756285613487782","article-title":"Targeting ion channels for the treatment of autoimmune neuroinflammation","volume":"6","author":"Bittner","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0075","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/brain\/awp163","article-title":"TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system","volume":"132","author":"Bittner","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.expneurol.2012.08.021","article-title":"The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis","volume":"238","author":"Bittner","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0090","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nri935","article-title":"Two-photon tissue imaging: seeing the immune system in a fresh light","volume":"2","author":"Cahalan","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/WCO.0b013e3283533a25","article-title":"Mitochondrial changes within axons in multiple sclerosis: an update","volume":"25","author":"Campbell","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.3411","article-title":"Regulatory T cell proliferative potential is impaired in human autoimmune disease","volume":"20","author":"Carbone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/glia.10145","article-title":"Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis","volume":"40","author":"Carson","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2009.01.012","article-title":"Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging","volume":"282","author":"Chard","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/brain\/awf025","article-title":"Brain atrophy in clinically early relapsing\u2013remitting multiple sclerosis","volume":"125","author":"Chard","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0120","series-title":"International Review of Neurobiology","doi-asserted-by":"crossref","DOI":"10.1016\/S0074-7742(07)79026-8","article-title":"Remyelination in multiple sclerosis","author":"Chari","year":"2007"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0125","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/glia.22367","article-title":"Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions","volume":"60","author":"Clarner","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0130","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1073\/pnas.0402765101","article-title":"Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+\/Ca2+ exchanger","volume":"101","author":"Craner","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/glia.20112","article-title":"Sodium channels contribute to microglia\/macrophage activation and function in EAE and MS","volume":"49","author":"Craner","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbadis.2010.06.010","article-title":"Mouse models for multiple sclerosis: historical facts and future implications","volume":"1812","author":"Croxford","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) \u2014 Mol. Basis Dis."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/jnnp.73.2.141","article-title":"Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis","volume":"73","author":"Dalton","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneur.58.1.65","article-title":"EVidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability","volume":"58","author":"De Stefano","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/ern.13.17","article-title":"Treating multiple sclerosis with monoclonal antibodies: a 2013 update","volume":"13","author":"Dei\u00df","year":"2013","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0160","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awl074","article-title":"The contribution of demyelination to axonal loss in multiple sclerosis","volume":"129","author":"Deluca","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0170","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/WNL.0b013e318249f6f0","article-title":"The evidence for a role of B cells in multiple sclerosis","volume":"78","author":"Disanto","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0175","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0180","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00417-011-1894-3","article-title":"Memantine for axonal loss of optic neuritis","volume":"250","author":"Esfahani","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0185","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: from biology to therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0190","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/nm1668","article-title":"Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system","volume":"13","author":"Friese","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0195","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis \u2014 the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0200","series-title":"Advances in Immunology","doi-asserted-by":"crossref","DOI":"10.1016\/S0065-2776(10)05004-2","article-title":"Chapter 4 \u2014 the family of IL-10-secreting CD4+ T cells","author":"Fujio","year":"2010"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrfmmm.2009.08.016","article-title":"Activated astroglia during chronic inflammation in Alzheimer's disease\u2014do they neglect their neurosupportive roles?","volume":"690","author":"Fuller","year":"2010","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(08)70191-1","article-title":"Grey matter pathology in multiple sclerosis","volume":"7","author":"Geurts","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0215","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S1474-4422(12)70230-2","article-title":"Measurement and clinical effect of grey matter pathology in multiple sclerosis","volume":"11","author":"Geurts","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2013.00045","article-title":"Origin and differentiation of microglia","volume":"7","author":"Ginhoux","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0225","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4049\/jimmunol.171.1.368","article-title":"Vulnerability of human neurons to T cell-mediated cytotoxicity","volume":"171","author":"Giuliani","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-9-41","article-title":"CD4+ CD25+ FoxP3+ regulatory T cells suppress cytotoxicity of CD8+ effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level","volume":"9","author":"Gobel","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0235","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/glia.22393","article-title":"Development and homeostasis of \u201cresident\u201d myeloid cells: the case of the microglia","volume":"61","author":"Gomez Perdiguero","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.285.5425.221","article-title":"The immunological synapse: a molecular machine controlling T cell activation","volume":"285","author":"Grakoui","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0245","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0250","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic Parkinsonism","volume":"51","author":"Hauser","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0260","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing\u2013remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0265","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ana.21867","article-title":"Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial","volume":"66","author":"Hawker","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0270","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00415-011-6212-9","article-title":"Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine","volume":"259","author":"Hayton","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.expneurol.2009.11.019","article-title":"Neurodegeneration in autoimmune CNS inflammation","volume":"225","author":"Herz","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0280","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1750-3639.1991.tb00646.x","article-title":"Migration of hematogenous cells through the blood\u2013brain barrier and the initiation of CNS inflammation","volume":"1","author":"Hickey","year":"1991","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1750-3639.2004.tb00496.x","article-title":"Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions","volume":"14","author":"H\u00f6ftberger","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0290","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-5728(00)00233-2","article-title":"The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis","volume":"107","author":"Hohlfeld","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0295","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ni1063","article-title":"Analysis of regulatory CD8 T cells in Qa-1-deficient mice","volume":"5","author":"Hu","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0300","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ni.f.215","article-title":"Shouts, whispers and the kiss of death: directional secretion in T cells","volume":"9","author":"Huse","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0305","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jnr.20482","article-title":"Microglia and multiple sclerosis","volume":"81","author":"Jack","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0310","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1474-4422(10)70131-9","article-title":"Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"9","author":"Kapoor","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0315","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(11)61649-8","article-title":"Ocrelizumab in relapsing\u2013remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial","volume":"378","author":"Kappos","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0320","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jneuroim.2003.10.001","article-title":"Clinical relapses of multiple sclerosis are associated with \u2018novel\u2019 valleys in natural killer cell functional activity","volume":"145","author":"Kastrukoff","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0325","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/aws159","article-title":"Natural killer cells and their receptors in multiple sclerosis","volume":"136","author":"Kaur","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0330","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.189.5.865","article-title":"Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?","volume":"189","author":"Kerschensteiner","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0335","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1523\/JNEUROSCI.5265-09.2010","article-title":"Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport","volume":"30","author":"Kiryu-Seo","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0340","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0345","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0922-4106(91)90113-V","article-title":"Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study","volume":"206","author":"Kornhuber","year":"1991","journal-title":"Eur. J. Pharmacol. Mol. Pharmacol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0350","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/glia.1085","article-title":"Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination","volume":"35","author":"Kotter","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0355","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrneurol.2012.203","article-title":"B cells and antibodies in multiple sclerosis pathogenesis and therapy","volume":"8","author":"Krumbholz","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0360","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.4049\/jimmunol.1300822","article-title":"The role of CD8+ T cells and their local interaction with CD4+ T cells in myelin oligodendrocyte glycoprotein35\u201355-induced experimental autoimmune encephalomyelitis","volume":"191","author":"Leuenberger","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0365","doi-asserted-by":"crossref","first-page":"RC16","DOI":"10.1523\/JNEUROSCI.19-14-j0002.1999","article-title":"Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na+-dependent glutamate transport","volume":"19","author":"Li","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0370","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/brain\/awq179","article-title":"Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis","volume":"133","author":"Linker","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0375","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.humimm.2006.02.020","article-title":"Immunoregulation of autoimmunity by natural killer T cells","volume":"66","author":"Linsen","year":"2005","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0380","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1567205053585846","article-title":"The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism","volume":"2","author":"Lipton","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0385","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0390","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/308274a0","article-title":"Proliferation of mature oligodendrocytes after trauma to the central nervous system","volume":"308","author":"Ludwin","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0395","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.intimp.2009.01.034","article-title":"Dysfunction of IL-10-producing type 1 regulatory T cells and CD4+ CD25+ regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys","volume":"9","author":"Ma","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0400","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/brain\/awn105","article-title":"Mitochondrial defects in acute multiple sclerosis lesions","volume":"131","author":"Mahad","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0405","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/brain\/awp046","article-title":"Mitochondrial changes within axons in multiple sclerosis","volume":"132","author":"Mahad","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0410","doi-asserted-by":"crossref","first-page":"e52361","DOI":"10.1371\/journal.pone.0052361","article-title":"Passive experimental autoimmune encephalomyelitis in C57BL\/6 with MOG: evidence of involvement of B cells","volume":"7","author":"Mannara","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0415","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature05478","article-title":"Foxp3 occupancy and regulation of key target genes during T-cell stimulation","volume":"445","author":"Marson","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0425","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archneur.65.12.noc80051","article-title":"Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab","volume":"65","author":"Martin","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0420","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4049\/jimmunol.0902238","article-title":"An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56bright NK cells","volume":"185","author":"Martin","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0430","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ana.410370415","article-title":"Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis","volume":"37","author":"Massacesi","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0435","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1084\/jem.20071053","article-title":"Neurofascin as a novel target for autoantibody-mediated axonal injury","volume":"204","author":"Mathey","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0440","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0166-2236(00)01746-X","article-title":"The link between excitotoxic oligodendroglial death and demyelinating diseases","volume":"24","author":"Matute","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0445","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.4049\/jimmunol.175.5.3025","article-title":"Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+ CD25+ regulatory cells within the central nervous system","volume":"175","author":"Mcgeachy","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0450","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"Mcgeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0455","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/1521-4141(200012)30:12<3623::AID-IMMU3623>3.0.CO;2-F","article-title":"MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas\/FasL, but not the perforin pathway","volume":"30","author":"Medana","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0460","doi-asserted-by":"crossref","first-page":"14559","DOI":"10.1074\/jbc.M800637200","article-title":"TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 critically influence T lymphocyte effector functions","volume":"283","author":"Meuth","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0465","doi-asserted-by":"crossref","first-page":"15397","DOI":"10.1523\/JNEUROSCI.4339-09.2009","article-title":"Cytotoxic CD8+ T cell\u2013neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death","volume":"29","author":"Meuth","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0470","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nature04474","article-title":"NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia","volume":"439","author":"Micu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0475","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/1352458510379243","article-title":"Altered M1\/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration","volume":"17","author":"Mikita","year":"2011","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0480","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0485","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","article-title":"Blood\u2013brain barrier disruption in multiple sclerosis","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0490","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1111\/j.1552-6569.2004.tb00273.x","article-title":"Pathogenesis of brain and spinal cord atrophy in multiple sclerosis","volume":"14","author":"Minagar","year":"2004","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0495","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1096\/fj.07-099499","article-title":"Interferon-\u03b3 directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-\u03b3 receptor and AMPA GluR1 receptor","volume":"22","author":"Mizuno","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0500","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(91)90321-L","article-title":"Increase of sodium channels in demyelinated lesions of multiple sclerosis","volume":"556","author":"Moll","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0505","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0510","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/awt041","article-title":"Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis","volume":"136","author":"Morsali","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0515","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0520","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1126\/science.7624779","article-title":"Induction of MHC class I genes in neurons","volume":"269","author":"Neumann","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0525","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.185.2.305","article-title":"Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-\u03b3 and Tumor necrosis factor (TNF)-\u03b1","volume":"185","author":"Neumann","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0530","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0166-2236(02)02154-9","article-title":"Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases","volume":"25","author":"Neumann","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0535","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1750-3639.2007.00101.x","article-title":"Glutamate receptor expression in multiple sclerosis lesions","volume":"18","author":"Newcombe","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0540","doi-asserted-by":"crossref","first-page":"e31959","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56bright NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0545","article-title":"Two-photon imaging of immune cells in neural tissue","volume":"3","author":"Niesner","year":"2013","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0550","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nm.2324","article-title":"A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"17","author":"Nikic","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0555","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(00)02659-3","article-title":"Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)","volume":"356","author":"Nitsch","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0560","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1523\/JNEUROSCI.4703-03.2004","article-title":"Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue","volume":"24","author":"Nitsch","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb9010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0565","first-page":"1","article-title":"HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients","volume":"0","author":"Pannemans","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0570","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/71555","article-title":"Glutamate excitotoxicity in a model of multiple sclerosis","volume":"6","author":"Pitt","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0575","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0580","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.brainresrev.2004.06.006","article-title":"Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease","volume":"46","author":"Raivich","year":"2004","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0585","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri1130","article-title":"Three or more routes for leukocyte migration into the central nervous system","volume":"3","author":"Ransohoff","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0590","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2013\/948976","article-title":"The benefits and detriments of macrophages\/microglia in models of multiple sclerosis","volume":"2013","author":"Rawji","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0595","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0600","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death","volume":"137","author":"Saijo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0605","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/nm.3015","article-title":"TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"18","author":"Schattling","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0610","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuron.2009.09.044","article-title":"MHC class I: an unexpected role in neuronal plasticity","volume":"64","author":"Shatz","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0615","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1177\/1352458511414755","article-title":"Intermediate-affinity interleukin-2 receptor expression predicts CD56bright natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis","volume":"17","author":"Sheridan","year":"2011","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2013.00006","article-title":"Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis","volume":"7","author":"Sierra","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0625","series-title":"Advances in Immunology","doi-asserted-by":"crossref","DOI":"10.1016\/S0065-2776(07)96001-0","article-title":"New insights into adaptive immunity in chronic neuroinflammation","author":"Siffrin","year":"2007"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0630","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.immuni.2010.08.018","article-title":"In vivo imaging of partially reversible Th17 cell-induced neuronal dysfunction in the course of encephalomyelitis","volume":"33","author":"Siffrin","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0635","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.it.2008.04.002","article-title":"Revival of CD8+ Treg-mediated suppression","volume":"29","author":"Smith","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0640","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/brain\/awh467","article-title":"Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3T","volume":"128","author":"Srinivasan","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0645","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4049\/jimmunol.163.1.40","article-title":"Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the \u201cResistant\u201d brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response","volume":"163","author":"Stefferl","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0650","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of TH17, the first major revision in the TH1\/TH2 hypothesis of T cell-mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0655","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/eji.200839073","article-title":"Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg","volume":"39","author":"Stephens","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0660","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archneur.63.10.1383","article-title":"Altered CD4+\/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis","volume":"63","author":"St\u00fcve","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0665","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.20858","article-title":"Immune surveillance in multiple sclerosis patients treated with natalizumab","volume":"59","author":"St\u00fcve","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0670","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awh219","article-title":"The regulatory role of natural killer cells in multiple sclerosis","volume":"127","author":"Takahashi","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention","volume":"208","author":"Tansey","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0680","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/brain\/awl213","article-title":"Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis","volume":"129","author":"Tischner","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0690","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(09)70043-2","article-title":"Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis","volume":"8","author":"Trapp","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0685","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0695","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0166-2236(99)01533-7","article-title":"A new concept in neurodegeneration: TNF\u03b1 is a silencer of survival signals","volume":"23","author":"Venters","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0700","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/brain\/awq337","article-title":"Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model","volume":"134","author":"Vergo","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0705","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000342388.73185.80","article-title":"Memantine induces reversible neurologic impairment in patients with MS","volume":"72","author":"Villoslada","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0710","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ana.21719","article-title":"Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"66","author":"Vogt","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0715","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn2023","article-title":"Axonal conduction and injury in multiple sclerosis: the role of sodium channels","volume":"7","author":"Waxman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0720","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0725","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0896-6273(02)00661-X","article-title":"The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory","volume":"34","author":"Wemmie","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0730","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.coph.2007.09.001","article-title":"Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases","volume":"8","author":"Xiong","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0735","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1523\/JNEUROSCI.23-09-03588.2003","article-title":"Functional hemichannels in astrocytes: a novel mechanism of glutamate release","volume":"23","author":"Ye","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2014.02.006_bb0740","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/brain\/awr110","article-title":"Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis","volume":"134","author":"Zambonin","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0745","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/10673229.2010.511059","article-title":"Glutamatergic modulators: the future of treating mood disorders?","volume":"18","author":"Zarate","year":"2010","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.02.006_bb0750","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/brain\/awf252","article-title":"Glatiramer acetate\u2010specific T\u2010helper 1\u2010 and 2\u2010type cell lines produce BDNF: implications for multiple sclerosis therapy","volume":"125","author":"Ziemssen","year":"2002","journal-title":"Brain"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861400051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861400051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T13:28:46Z","timestamp":1688995726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448861400051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":151,"alternative-id":["S001448861400051X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.02.006","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms linking neuroinflammation and neurodegeneration in MS","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}